Berit Lange

Latest

• Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
• Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
• Risk assessment of tuberculosis in immunocompromised patients. A TBNET study